• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of amjpatholAmerican Journal of Pathology For AuthorsAmerican Journal of Pathology SubscribeAmerican Journal of Pathology SearchAmerican Journal of Pathology Current IssueAmerican Journal of Pathology About the JournalAmerican Journal of Pathology
Am J Pathol. Mar 1988; 130(3): 455–465.
PMCID: PMC1880682

Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.

Abstract

Fibrinogen enters wounds and solid tumors, where it is clotted to fibrin that may subsequently be replaced by collagenous stroma. If, as has been suggested, the pathogenesis of wound healing and tumor stroma generation is similar and dependent on fibrin deposition, then the types and amounts of fibrin deposited in wounds and tumors might also be expected to be similar. To test this hypothesis, the authors injected homologous tracer fibrinogen (125I-GPF) intravenously into guinea pigs and measured its influx and accumulation in skin wounds and syngeneic carcinomas. In support of their hypothesis, the urea-insoluble product deposited in both wounds and tumors was identified as cross-linked fibrin by gel electrophoresis. Accumulation of both total and urea-insoluble 125I-GPF was quantitatively similar in wounds and tumors. However, influx and initial clotting of 125I-GPF in tumors exceeded that in wounds; given equivalent accumulation, these data suggest that fibrin turnover is more rapid in tumors than in wounds. Fibrinogen influx and fibrin accumulation declined toward normal a few days after wounding but remained consistently elevated in tumors. Thus, the magnitude and the persistence of microvascular hyperpermeability, as well as fibrin turnover, are major points of difference that distinguish tumors from healing wounds.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203. [PubMed]
  • Tremblay G. Stromal aspects of breast carcinoma. Exp Mol Pathol. 1979 Aug;31(1):248–260. [PubMed]
  • Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986 Dec 25;315(26):1650–1659. [PubMed]
  • Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM, Rypysc J, Giovinco P. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol. 1979 Jan;122(1):166–174. [PubMed]
  • Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983 Feb 25;219(4587):983–985. [PubMed]
  • Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986 Nov;46(11):5629–5632. [PubMed]
  • Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst. 1979 Jun;62(6):1459–1472. [PubMed]
  • Dvorak HF, Senger DR, Dvorak AM. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev. 1983;2(1):41–73. [PubMed]
  • Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, Carvalho AC. Tumor shedding and coagulation. Science. 1981 May 22;212(4497):923–924. [PubMed]
  • Dvorak HF, Harvey VS, McDonagh J. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res. 1984 Aug;44(8):3348–3354. [PubMed]
  • O'MEARA RA, JACKSON RD. Cytological observations on carcinoma. Ir J Med Sci. 1958 Jul;(391):327–328. [PubMed]
  • DAY ED, PLANINSEK JA, PRESSMAN D. Localization in vivo of radio-iodinated anti-rat-fibrin antibodies and radio-iodinated rat fibrinogen in the Murphy rat lymphosarcoma and in other transplantable rat tumors. J Natl Cancer Inst. 1959 Feb;22(2):413–426. [PubMed]
  • Spar IL, Bale WF, Marrack D, Dewey WC, McCardle RJ, Harper PV. 131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials. Cancer. 1967 May;20(5):865–870. [PubMed]
  • HIRAMOTO R, BERNECKY J, JURANDOWSKI J, PRESSMAN D. Fibrin in human tumors. Cancer Res. 1960 Jun;20:592–593. [PubMed]
  • Dvorak HF, Dickersin GR, Dvorak AM, Manseau EJ, Pyne K. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst. 1981 Aug;67(2):335–345. [PubMed]
  • Harris NL, Dvorak AM, Smith J, Dvorak HF. Fibrin deposits in Hodgkin's disease. Am J Pathol. 1982 Jul;108(1):119–129. [PMC free article] [PubMed]
  • Dvorak HF, Van DeWater L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho AC. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res. 1983 Sep;43(9):4434–4442. [PubMed]
  • VanDeWater L, Tracy PB, Aronson D, Mann KG, Dvorak HF. Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res. 1985 Nov;45(11 Pt 1):5521–5525. [PubMed]
  • Pineo GF, Brain MC, Gallus AS, Hirsh J, Hatton MW, Regoeczi E. Tumors, mucus production, and hypercoagulability. Ann N Y Acad Sci. 1974;230:262–270. [PubMed]
  • Dvorak HF, Form DM, Manseau EJ, Smith BD. Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J Natl Cancer Inst. 1984 Nov;73(5):1195–1205. [PubMed]
  • Form DM, VanDeWater L, Dvorak HF, Smith BD. Pathogenesis of tumor desmoplasia. II. Collagens synthesized by line 1 and line 10 guinea pig carcinoma cells and by syngeneic fibroblasts in vitro. J Natl Cancer Inst. 1984 Nov;73(5):1207–1214. [PubMed]
  • Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975 Jan;78(1):71–100. [PMC free article] [PubMed]
  • Churchill WH, Jr, Rapp HJ, Kronman BS, Borsos T. Detection of antigens of a new diethylnitrosamine-induced transplantable hepatoma by delayed hypersensitivity. J Natl Cancer Inst. 1968 Jul;41(1):13–29. [PubMed]
  • Hubbard AL, Cohn ZA. The enzymatic iodination of the red cell membrane. J Cell Biol. 1972 Nov;55(2):390–405. [PMC free article] [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Hermans J, McDonagh J. Fibrin: structure and interactions. Semin Thromb Hemost. 1982 Jan;8(1):11–24. [PubMed]
  • Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J. Regulation of extravascular coagulation by microvascular permeability. Science. 1985 Mar 1;227(4690):1059–1061. [PubMed]
  • Francis CW, Markham RE, Jr, Marder VJ. Demonstration of in situ fibrin degradation in pathologic thrombi. Blood. 1984 May;63(5):1216–1224. [PubMed]
  • Budzynski AZ, Marder VJ, Parker ME, Shames P, Brizuela BS, Olexa SA. Antigenic markers on fragment DD, a unique plasmic derivative of human crosslinked fibrin. Blood. 1979 Oct;54(4):794–804. [PubMed]
  • Gaffney PJ, Brasher M, Lord K, Strachan CJ, Wilkinson AR, Kakkar VV, Scully MF. Fibrin subunits in venous and arterial thromboembolism. Cardiovasc Res. 1976 Jul;10(4):421–426. [PubMed]
  • O'Connor SW, Bale WF. Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res. 1984 Sep;44(9):3719–3723. [PubMed]
  • DEWEY WC. Vascular-extravascular exchange of II31 plasma proteins in the rat. Am J Physiol. 1959 Aug;197:423–431. [PubMed]
  • Song CW, Levitt SH. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res. 1971 May;31(5):587–589. [PubMed]
  • Peterson HI, Appelgren L, Lundborg G, Rosengren B. Capillary permeability of two transplantable rat tumours as compared with various normal organs of the rat. Bibl Anat. 1973;12:511–518. [PubMed]
  • Ackerman NB, Hechmer PA. Studies on the capillary permeability of experimental liver metastases. Surg Gynecol Obstet. 1978 Jun;146(6):884–888. [PubMed]
  • SCHOEFL GI. STUDIES ON INFLAMMATION. III. GROWING CAPILLARIES: THEIR STRUCTURE AND PERMEABILITY. Virchows Arch Pathol Anat Physiol Klin Med. 1963 Nov 8;337:97–141. [PubMed]
  • Herold G, Neier WE, Straub PW. Surface accumulation and reduced survival of I 125 -fibrinogen during wound healing. Helv Med Acta. 1973;37(1):57–61. [PubMed]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...